Offer extended until 31 July 2026: get a 10% early-bird discount on all events starting on or after 25 August 2026. To the promotion
GMP search engine – look up GMP compliance regulations and news
ANVISA recognises CEPs
Recommendation
6/7 October 2026
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
At the beginning of December, a news in the EDQM website newsroom informed that the Brazilian health authority ANVISA (Agência Nacional de Vigilância Sanitária) has started to recognise evaluation reports and documents from other authorities as part of its assessments. This includes, for example, the CEP of the EDQM, which can now be used when applying for the 'Letter of Suitability of the Active Pharmaceutical Ingredient (CADIFA)' and can therefore provide support when applying for medicinal products in Brazil.
Other authorities whose evaluations are now recognised are listed below:
- European Medicines Agency (EMA)
- Health Canada
- World Health Organisation (WHO)
- Swissmedic
- UK Medicines and Healthcare products Regulatory Agency (MHRA)
- US Food and Drug Administration (FDA)
- Australian Therapeutic Goods Administration (TGA)
Further information can be found in the newsroom on the EDQM website.
Related GMP News
10.06.2026EDQM publishes revised CEP Guideline
27.05.2026What should you know about EU and US Drug Approval? Part 2
20.05.2026What should you know about EU and US drug approval? Part 1
18.03.2026ICH M4Q(R2): List of comments published
11.03.2026ASMF: CMDh updates Information on "Worksharing Procedure"